<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01235624</url>
  </required_header>
  <id_info>
    <org_study_id>UF 8300</org_study_id>
    <secondary_id>2008-A01238-47</secondary_id>
    <nct_id>NCT01235624</nct_id>
  </id_info>
  <brief_title>Autosomal Dominant Retinitis Pigmentosa: Prevalence of Known Genes Identification of New Loci / Genes</brief_title>
  <official_title>Autosomal Dominant Retinitis Pigmentosa: Prevalence of Known Genes Identification of New Loci / Genes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Identify new genes responsible for autosomal dominant retinitis pigmentosa (ADRP), one of the
      most common causes of hereditary diseases of the retina, and thus better understand the
      mechanisms involved of the disease.&quot;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Two hundred and fifty samples from unrelated patients, from which 150 were provided by the
      national reference center of rare disease in Montpellier and 100 recruited in the 9
      participating centers over a period of two years.&quot;To identify the missing genes, we proceed
      in two steps. A first step in selecting families negative for the 8 major genes genes, by
      systematic sequencing of exons most frequently involved. A second step in finding new loci /
      genes by locus exclusion using microsatellite markers and SNP genotyping.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>identification of unknown loci and genes responsible of Autosomal dominant retinitis pigmentosa (adRP)</measure>
    <time_frame>for 5 years</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">1161</enrollment>
  <condition>Autosomal Dominant Retinitis Pigmentosa</condition>
  <arm_group>
    <arm_group_label>patient</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patient suffering of adRP that accept to participate at this study have a blood prelevement for genetic analysis (intervention)</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>genetic analysis</intervention_name>
    <arm_group_label>patient</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  retinitis pigmentosa diagnosed

          -  Autosomal dominant transmission diagnosed

          -  Aged from 5 to 80 years

          -  Informed consent

          -  Affiliated or benefit from an insurance regimen

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>christian HAMEL, Pr Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut National de la Santé Et de la Recherche Médicale, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>José-Alain SAHEL, Pr</last_name>
    <role>Study Chair</role>
    <affiliation>§ Centre hospitalier national d'ophtalmologie des XV-XX, Paris,FRANCE</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean Louis DUFIER, Pr</last_name>
    <role>Study Chair</role>
    <affiliation>Hopital Necker enfants-malades,Paris,FRANCE</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hélène DOLLFUS, Pr</last_name>
    <role>Study Chair</role>
    <affiliation>CHU de STRASBOURG, FRANCE</affiliation>
  </overall_official>
  <overall_official>
    <last_name>sylvie ODENT, Pr</last_name>
    <role>Study Chair</role>
    <affiliation>CHU de RENNES Unité INSERM 598,Paris,FRANCE</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sabine DEFOORT- DHELEMMES, Ph.D</last_name>
    <role>Study Chair</role>
    <affiliation>CHRU de LILLE,FRANCE</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michel WEBER, Pr</last_name>
    <role>Study Chair</role>
    <affiliation>CHU de NANTES,FRANCE</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xavier ZANLONGH, Ph.D</last_name>
    <role>Study Chair</role>
    <affiliation>CLINIQUE SOURDILLE, NANTES,France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Laurence LO OLIVIER-FAIVRE, PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre génétique Médicale - Children Hospital of DIJON</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHRU Montpellier</name>
      <address>
        <city>Montpellier</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Audo I, Manes G, Mohand-Saïd S, Friedrich A, Lancelot ME, Antonio A, Moskova-Doumanova V, Poch O, Zanlonghi X, Hamel CP, Sahel JA, Bhattacharya SS, Zeitz C. Spectrum of rhodopsin mutations in French autosomal dominant rod-cone dystrophy patients. Invest Ophthalmol Vis Sci. 2010 Jul;51(7):3687-700. doi: 10.1167/iovs.09-4766. Epub 2010 Feb 17.</citation>
    <PMID>20164459</PMID>
  </results_reference>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 4, 2010</study_first_submitted>
  <study_first_submitted_qc>November 4, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 5, 2010</study_first_posted>
  <last_update_submitted>November 5, 2013</last_update_submitted>
  <last_update_submitted_qc>November 5, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 6, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Autosomal dominant retinitis pigmentosa</keyword>
  <keyword>Rare disease</keyword>
  <keyword>Genetics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinitis</mesh_term>
    <mesh_term>Retinitis Pigmentosa</mesh_term>
    <mesh_term>Cone-Rod Dystrophies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

